Menú

GREMPAL
Grup de Recerca en Malalties Prevalents de l´Aparell Locomotor en Atenció Primària (GREMPAL)

Responsable del grupo
fundanet_file_Investigador4053-2
Daniel Martínez Laguna
dmartinezl.bcn.ics@gencat.cat
avatar_grups_recerca.png

Publicaciones

Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain

E. BURN, E. ROEL, A. PISTILLO, S. FERNANDEZ-BERTOLIN, M. ARAGON, B. RAVENTOS, C. REYES, K. VERHAMME, P. RIJNBEEK, X. LI, V. STRAUSS, D. PRIETO-ALHAMBRA and T. DUARTE-SALLES
NATURE COMMUNICATIONS. 2022 Nov 23; . doi:10.1038/s41467-022-34669-9; PMID:36418321

Ver más:
Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom

E. BURN, X. LI, A. DELMESTRI, N. JONES, T. DUARTE-SALLES, C. REYES, E. MARTINEZ-HERNANDEZ, E. MARTI, K. VERHAMME, P. RIJNBEEK, V. STRAUSS and D. PRIETO-ALHAMBRA
NATURE COMMUNICATIONS. 2022 Nov 23; . doi:10.1038/s41467-022-34668-w; PMID:36418291

Ver más:
Development and external validation of a 1-and 5-year fracture prediction tool based on electronic medical records data: The EPIC risk algorithm

C. TEBE, N. PALLARES, C. REYES, C. CARBONELL-ABELLA, D. MONTERO-COROMINAS, E. MARTIN-MERINO, X. NOGUES, A. DIEZ-PEREZ, D. PRIETO-ALHAMBRA and D. MARTINEZ-LAGUNA
BONE. 2022 Sep 1; . doi:10.1016/j.bone.2022.116469; PMID:35691583

Ver más:
Secular trends of dispensed opioid prescriptions in Catalonia, Spain, 2007-19: A population-based cohort study of over 5 million individuals

J. XIE, V. STRAUSS, G. COLLINS, S. KHALID, A. DELMESTRI, A. TURKIEWICZ, M. ENGLUND, M. TADROUS, C. REYES and D. PRIETO-ALHAMBRA
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022 Sep 1;

Ver más:
The impact of COVID-19 on population-level drug utilization of alendronate in five European databases

E. TAN, D. ROBINSON, A. JOEDICKE, M. SANCHEZ-SANTOS, M. MOSSEVELD, K. NIELSEN, C. REYES, A. VOSS, E. MARCONI, F. LAPI, J. REINOLD, K. VERHAMME, L. PEDERSEN, M. DE WILDE, M. RUIZ, M. ARAGON, P. BOSCO-LEVY, R. LASSALLE and D. PRIETO-ALHAMBRA
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022 Sep 1;

Ver más: